These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 17587637)

  • 1. Immune response induced by recombinant Mycobacterium bovis BCG expressing ROP2 gene of Toxoplasma gondii.
    Wang H; Liu Q; Liu K; Zhong W; Gao S; Jiang L; An N
    Parasitol Int; 2007 Dec; 56(4):263-8. PubMed ID: 17587637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the immune response elicited by multi-antigenic DNA vaccine expressing SAG1, ROP2 and GRA2 against Toxoplasma gondii.
    Xue M; He S; Cui Y; Yao Y; Wang H
    Parasitol Int; 2008 Dec; 57(4):424-9. PubMed ID: 18562245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GRA7 provides protective immunity in cocktail DNA vaccines against Toxoplasma gondii.
    Jongert E; de Craeye S; Dewit J; Huygen K
    Parasite Immunol; 2007 Sep; 29(9):445-53. PubMed ID: 17727568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on the immuno-protection of ROP2 nuclei acid vaccine in Toxoplasma gondii infection].
    Wei QK; Li J; Fu TX; Bai XL; Cui Y; Zhang DB; Wang HF; Liu YB; Fu B; Zai DF; Huang BC; Liu KY; Han GD
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2006 Oct; 24(5):337-41. PubMed ID: 17361811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxoplasma gondii: the immunogenic and protective efficacy of recombinant ROP2 and ROP4 rhoptry proteins in murine experimental toxoplasmosis.
    Dziadek B; Gatkowska J; Brzostek A; Dziadek J; Dzitko K; Dlugonska H
    Exp Parasitol; 2009 Sep; 123(1):81-9. PubMed ID: 19508869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the immune response induced by DNA vaccine cocktail expressing complete SAG1 and ROP2 genes against toxoplasmosis.
    Hoseinian Khosroshahi K; Ghaffarifar F; D'Souza S; Sharifi Z; Dalimi A
    Vaccine; 2011 Jan; 29(4):778-83. PubMed ID: 21095254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological response of sheep to injections of plasmids encoding Toxoplasma gondii SAG1 and ROP1 genes.
    Li B; Oledzka G; McFarlane RG; Spellerberg MB; Smith SM; Gelder FB; Kur J; Stankiewicz M
    Parasite Immunol; 2010; 32(9-10):671-83. PubMed ID: 20691019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction and immunogenicity of pseudotype baculovirus expressing Toxoplasma gondii SAG1 protein in BALB/c mice model.
    Fang R; Feng H; Nie H; Wang L; Tu P; Song Q; Zhou Y; Zhao J
    Vaccine; 2010 Feb; 28(7):1803-7. PubMed ID: 20018269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study on construction and immune protective effect of recombinant nucleic acid vaccine of Toxoplasma gondii].
    Wei QK
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2012 Apr; 24(2):173-7, 182. PubMed ID: 22799162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of a DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice.
    Qu D; Wang S; Cai W; Du A
    Vaccine; 2008 Aug; 26(35):4541-8. PubMed ID: 18590785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxoplasma gondii: DNA vaccination with genes encoding antigens MIC2, M2AP, AMA1 and BAG1 and evaluation of their immunogenic potential.
    Dautu G; Munyaka B; Carmen G; Zhang G; Omata Y; Xuenan X; Igarashi M
    Exp Parasitol; 2007 Jul; 116(3):273-82. PubMed ID: 17379212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis.
    Dziadek B; Gatkowska J; Brzostek A; Dziadek J; Dzitko K; Grzybowski M; Dlugonska H
    Vaccine; 2011 Jan; 29(4):821-30. PubMed ID: 21087690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxoplasma gondii immune mapped protein-1 (TgIMP1) is a novel vaccine candidate against toxoplasmosis.
    Cui X; Lei T; Yang D; Hao P; Li B; Liu Q
    Vaccine; 2012 Mar; 30(13):2282-7. PubMed ID: 22310204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect against toxoplasmosis in mice induced by DNA immunization with gene encoding Toxoplasma gondii ROP18.
    Yuan ZG; Zhang XX; Lin RQ; Petersen E; He S; Yu M; He XH; Zhou DH; He Y; Li HX; Liao M; Zhu XQ
    Vaccine; 2011 Sep; 29(38):6614-9. PubMed ID: 21762755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA immunization with eukaryotic initiation factor-2α of Toxoplasma gondii induces protective immunity against acute and chronic toxoplasmosis in mice.
    Chen J; Huang SY; Zhou DH; Li ZY; Petersen E; Song HQ; Zhu XQ
    Vaccine; 2013 Dec; 31(52):6225-31. PubMed ID: 24183979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Construction of monovalent and compound nucleic acid vaccines against Toxoplasma gondii with gene encoding p30].
    Yang TT; He SY; Jiang H; Gu QM; Cong H; Zhou HY; Zhang JQ; Li Y; Zhao QL
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2005 Feb; 23(1):14-7. PubMed ID: 16042200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunity induced by DNA vaccine of plasmid encoding the rhoptry protein 1 gene combined with the genetic adjuvant of pcIFN-gamma against Toxoplasma gondii in mice.
    Guo H; Chen G; Lu F; Chen H; Zheng H
    Chin Med J (Engl); 2001 Mar; 114(3):317-20. PubMed ID: 11780322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxoplasma gondii: protective effect of an intranasal SAG1 and MIC4 DNA vaccine in mice.
    Wang H; He S; Yao Y; Cong H; Zhao H; Li T; Zhu XQ
    Exp Parasitol; 2009 Jul; 122(3):226-32. PubMed ID: 19366622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on immuno-effect with GRA4 or SAG2 gene recombinant BCG vaccine of Toxoplasma gondii].
    Li JH; Wu ST; Weng YB; Gan Y; Liu HB; Liu ML; Zhang RL; Gao ST; Huang DN; Geng YJ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Jun; 25(3):217-21. PubMed ID: 18038782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent antigen-specific immunity to Toxoplasma gondii in adjuvant-free vaccination system using Rop2-Leishmania infantum Hsp83 fusion protein.
    Echeverria PC; de Miguel N; Costas M; Angel SO
    Vaccine; 2006 May; 24(19):4102-10. PubMed ID: 16545504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.